HArmonyCaᵀᴹ

Combining hyaluronic acid (HA) with calcium hydroxyapatite (CaHA), HArmonyCa is a dual effect injectable that provides an instant lift and sustained collagen stimulation for firm, rejuvenated skin*,†,§.

Visit our website https://www.harmonyca.uk/ and follow us @HArmonyCaUK on Instagram to find out more!

* Results from a prospective and non-randomised interventional study where HArmonyCa™ was injected in the preauricular region of 15 women. The primary endpoint were the volumetric changes at Day 180. Secondary endpoints included changes in facial tension vectors, time to filler tissue integration and safety profile.

† Ultrasound and elastography examinations were performed. When compared to baseline, an increase in density, viscoelasticity, and firmness of the tissue was observed at 60 days and then confirmed at 90 days after treatment. At 180 days after treatment an increase in collagen in the treated areas was confirmed.

§ Results based on a pre-clinical animal study of HArmonyCa™ with results demonstrated over 12 weeks, which showed that HArmonyCa™ led to an instant lifting-effect following injection.

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or via the MHRA Yellow Card app, available at Google Play or Apple App stores.

Adverse events should also be reported to AbbVie on ProductSurveillance_EAME@allergan.com.
Intended for UK Healthcare Professionals only.

HArmonyCaᵀᴹ is intended for those over the age of 18 years.
Produced and funded by Allergan Aesthetics, an AbbVie company.

UK-AGNA-250264 | December 2025